AU2002214041A1 - Diagnosis of diseases associated with the human c-mos gene - Google Patents

Diagnosis of diseases associated with the human c-mos gene

Info

Publication number
AU2002214041A1
AU2002214041A1 AU2002214041A AU1404102A AU2002214041A1 AU 2002214041 A1 AU2002214041 A1 AU 2002214041A1 AU 2002214041 A AU2002214041 A AU 2002214041A AU 1404102 A AU1404102 A AU 1404102A AU 2002214041 A1 AU2002214041 A1 AU 2002214041A1
Authority
AU
Australia
Prior art keywords
human
mos gene
diagnosis
diseases associated
mos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214041A
Inventor
Kurt Berlin
Alexander Olek
Christian Piepenbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of AU2002214041A1 publication Critical patent/AU2002214041A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the chemically modified genomic sequence of the human C-mos gene, to oligonucleotides and/or PNA oligomers directed against the sequence for detecting the cytosine methylation condition of the human C-mos gene and to a method for determining genetic and/or epigenetic parameters of the human C-mos gene.
AU2002214041A 2000-11-06 2001-11-06 Diagnosis of diseases associated with the human c-mos gene Abandoned AU2002214041A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054972.1 2000-11-06
DE2000154972 DE10054972A1 (en) 2000-11-06 2000-11-06 Diagnosis of diseases associated with humus
PCT/EP2001/012831 WO2002036604A2 (en) 2000-11-06 2001-11-06 Diagnosis of diseases associated with the human c-mos gene

Publications (1)

Publication Number Publication Date
AU2002214041A1 true AU2002214041A1 (en) 2002-05-15

Family

ID=7662311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214041A Abandoned AU2002214041A1 (en) 2000-11-06 2001-11-06 Diagnosis of diseases associated with the human c-mos gene

Country Status (6)

Country Link
US (1) US20040048278A1 (en)
EP (1) EP1339873B1 (en)
AT (1) ATE350489T1 (en)
AU (1) AU2002214041A1 (en)
DE (2) DE10054972A1 (en)
WO (1) WO2002036604A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7617163B2 (en) * 1998-05-01 2009-11-10 Health Discovery Corporation Kernels and kernel methods for spectral data
WO2001077164A2 (en) 2000-04-06 2001-10-18 Epigenomics Ag Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
DE10128508A1 (en) 2001-06-14 2003-02-06 Epigenomics Ag Methods and nucleic acids for the differentiation of prostate tumors
WO2006088978A1 (en) 2005-02-16 2006-08-24 Epigenomics, Inc. Method for determining the methylation pattern of a polynucleic acid
US7932027B2 (en) 2005-02-16 2011-04-26 Epigenomics Ag Method for determining the methylation pattern of a polynucleic acid
SI1871912T1 (en) 2005-04-15 2012-06-29 Epigenomics Ag Method for determining DNA methylation in blood or urine samples
ES2946143T3 (en) 2017-09-30 2023-07-13 Certainteed Gypsum Inc Tapered section gypsum boards and methods of manufacturing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330929A1 (en) * 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
WO1999064627A2 (en) * 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
DE19905082C1 (en) * 1999-01-29 2000-05-18 Epigenomics Gmbh Identification of methylation patterns of cytosine in genome DNA comprises chemical treatment to produce different base pairing behavior between cytosine and 5-methylcytosine
DE10128508A1 (en) * 2001-06-14 2003-02-06 Epigenomics Ag Methods and nucleic acids for the differentiation of prostate tumors
EP1502222A2 (en) * 2001-07-02 2005-02-02 Epigenomics AG A distributed system for epigenetic based prediction of complex phenotypes

Also Published As

Publication number Publication date
US20040048278A1 (en) 2004-03-11
DE10054972A1 (en) 2002-06-06
ATE350489T1 (en) 2007-01-15
WO2002036604A2 (en) 2002-05-10
EP1339873B1 (en) 2007-01-03
DE50111824D1 (en) 2007-02-15
WO2002036604A3 (en) 2002-08-08
EP1339873A2 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
WO2002000928A3 (en) Diagnosis of diseases associated with the immune system by determining cytosine methylation
WO2001077378A3 (en) Diagnosis of diseases associated with dna adducts
WO2001068912A3 (en) Diagnosis of diseases associated with tumor suppressor genes and oncogenes
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2003052135A3 (en) Method and nucleic acids for the analysis of a lung cell proliferative disorder
WO2002046454A3 (en) Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2002036814A3 (en) Diagnosis of diseases associated with cdk4 by determining the methylation state of the cdk4
WO2003014388A3 (en) Method and nucleic acids for the analysis of colon cancer
AU2002214041A1 (en) Diagnosis of diseases associated with the human c-mos gene
WO2002012554A3 (en) Diagnosis of diseases which are associated with cd24
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001051670A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001038586A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001047942A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof